Allspring Global Investments Holdings LLC cut its position in CME Group Inc. (NASDAQ:CME – Free Report) by 26.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 72,048 shares of the financial services provider’s stock after selling 25,595 shares during the period. Allspring Global Investments Holdings LLC’s holdings in CME Group were worth $21,394,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of CME. Vanguard Group Inc. grew its holdings in shares of CME Group by 1.7% during the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock worth $9,802,366,000 after purchasing an additional 588,509 shares during the last quarter. State Street Corp increased its position in CME Group by 0.4% in the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock worth $4,408,747,000 after purchasing an additional 56,725 shares during the period. Norges Bank acquired a new stake in CME Group in the fourth quarter worth about $1,523,241,000. Bank of New York Mellon Corp raised its holdings in CME Group by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after purchasing an additional 134,242 shares during the last quarter. Finally, Raymond James Financial Inc. raised its holdings in CME Group by 5.4% during the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock worth $1,179,858,000 after purchasing an additional 222,890 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.
Wall Street Analyst Weigh In
CME has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft reduced their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Piper Sandler reduced their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. UBS Group lowered their price target on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Finally, Barclays cut their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Moderate Buy” and an average price target of $292.12.
Insider Transactions at CME Group
In other news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction on Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by insiders.
CME Group Trading Up 0.0%
NASDAQ:CME opened at $245.11 on Tuesday. The business’s 50-day simple moving average is $257.79 and its 200-day simple moving average is $281.93. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $88.82 billion, a PE ratio of 20.91, a price-to-earnings-growth ratio of 3.05 and a beta of 0.25.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.80 earnings per share. Sell-side analysts expect that CME Group Inc. will post 12.18 earnings per share for the current fiscal year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is 44.37%.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
